Publications by authors named "Julia Gee"

Claim this Profile
A
A statistical approach to automated analysis of the low-contrast object detectability test for the large ACR MRI phantom.
Ali M Golestani, Julia M Gee

J Appl Clin Med Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative Stress-Responsive 1 Kinase Catalytic Activity Promotes Triple Negative Breast Cancer Oncogenic Potential.
Azeza M Fdel, Loren Waters, Ira Sharma, Samuel Jones, Julia Gee

ACS Pharmacol Transl Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smart Compression Sock for Early Detection of Diabetic Foot Ulcers.
Julia Billings, Julia Gee, Zinah Ghulam, Hussein A Abdullah

Sensors (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Susceptibility to Carbon Dioxide Gas in Three Rat Strains Using the Loss of Righting Reflex.
Dexter R Merenick, Brittany A Munro, Julia M Gee, Daniel Sj Pang

J Am Assoc Lab Anim Sci· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.
Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman, Elyssa Campbell, Kee-Ming Chia, Julia M W Gee

Nat Struct Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Loss of Righting Reflex to Assess Susceptibility to Carbon Dioxide Gas in Three Mouse Strains.
Brittany A Munro, Dexter R Merenick, Julia M Gee, Daniel Sj Pang

J Am Assoc Lab Anim Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulvestrant plus vandetanib versus placebo for the treatment of patients with metastatic breast cancer resistant to aromatase inhibitor therapy (FURVA): a multicentre, Phase 2, randomised controlled trial.
Mark Beresford, Angela Casbard, Zoe Hudson, Margherita Carucci, Kate Ingarfield, Julia Gee

BJC Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyridine based dual binding site aromatase (CYP19A1) inhibitors.
Ahmed G Eissa, Lauren E Powell, Julia Gee, Paul A Foster, Claire Simons

RSC Med Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucocorticoid induced loss of oestrogen receptor alpha gene methylation and restoration of sensitivity to fulvestrant in triple negative breast cancer.
Haya Intabli, Julia M Gee, Steffi Oesterreich, Mark S Yeoman, Marcus C Allen

Gene· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT).
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Julia M W Gee

Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors.
Ahmed G Eissa, Denise Barrow, Julia Gee, Lauren E Powell, Paul A Foster

Eur J Med Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.
Jodi M Saunus, Xavier M De Luca, Korinne Northwood, Ashwini Raghavendra, Alexander Hasson, Julia M W Gee

NPJ Breast Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of targeting signalling mechanisms of the SLC39A family of zinc transporters to inhibit endocrine resistant breast cancer.
Samuel Jones, Georgia Farr, Thirayost Nimmanon, Silvia Ziliotto, Julia M W Gee

Explor Target Antitumor Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis.
Thirayost Nimmanon, Silvia Ziliotto, Olivia Ogle, Anna Burt, Julia M W Gee

Cell Mol Life Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER Invasive Breast Cancer (STAKT).
John F R Robertson, Robert E Coleman, Kwok-Leung Cheung, Abigail Evans, Chris Holcombe, Julia M W Gee

Clin Cancer Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Joanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu, Katherine A Giles, C Elizabeth Caldon, Julia M W Gee

Nat Commun· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activated zinc transporter ZIP7 as an indicator of anti-hormone resistance in breast cancer.
Silvia Ziliotto, Julia M W Gee, Ian O Ellis, Andrew R Green, Pauline Finlay

Metallomics· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAK4 regulates stemness and progression in endocrine resistant ER-positive metastatic breast cancer.
Angélica Santiago-Gómez, Thomas Kedward, Bruno M Simões, Ilaria Dragoni, Roisin NicAmhlaoibh, Julia M Gee

Cancer Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer.
Michael J G Milevskiy, Udai Gujral, Carolina Del Lama Marques, Andrew Stone, Korinne Northwood, Julia M W Gee

Br J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.
Iain R Hutcheson, Janice M Knowlden, Steve E Hiscox, Denise Barrow, Julia M W Gee

Breast Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP.
Luke Piggott, Andreia Silva, Timothy Robinson, Angelica Santiago-Gómez, Bruno M Simões, Julia Gee

Clin Cancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Michael J G Milevskiy, Fares Al-Ejeh, Jodi M Saunus, Korinne S Northwood, Peter J Bailey, Julia M W Gee

Hum Mol Genet· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance.
Rebecca Bellerby, Chris Smith, Sue Kyme, Julia Gee, Ursula Günthert

Front Oncol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines.
Zana Azeez Abdulkareem, Julia Mw Gee, Charles D Cox, Kenneth T Wann

Br J Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
David Gallego-Ortega, Anita Ledger, Daniel L Roden, Andrew M K Law, Astrid Magenau, Julia M W Gee

PLoS Biol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis